David E. Darden

An investigation of the relationship between caloric intake and outcome in hospitalized dogs.

Rebecca L. Remillard, David E. Darden, K. Michel et al. · PubMed · 2001 · 49 citations

Agriculture, Nutrition, Nutritional Sciences +17

Safety and Efficacy of Venetoclax Plus Low-Dose Cytarabine in Treatment-Naive Patients Aged ≥65 Years with Acute Myeloid Leukemia

Andrew H. Wei, Stephen A. Strickland, Gail J. Roboz et al. · Blood · 2016 · 45 citations

Medicine, Hematology, Pharmacology +13

The BCL-2-Specific BH3-Mimetic ABT-199 (GDC-0199) Is Active and Well-Tolerated in Patients with Relapsed Non-Hodgkin Lymphoma: Interim Results of a Phase I Study

Matthew S. Davids, Andrew W. Roberts, Mary Ann Anderson et al. · Blood · 2012 · 40 citations

Medicine, Oncology, Pharmacology +16

Phase Ib/2 study of venetoclax with low-dose cytarabine in treatment-naive patients age ≥ 65 with acute myelogenous leukemia.

Tara L. Lin, Stephen A. Strickland, Walter Fiedler et al. · Journal of Clinical Oncology · 2016 · 35 citations

Medicine, Pharmacology, Pharmacotherapy +16

Updated results of a phase I first-in-human study of the BCL-2 inhibitor ABT-199 (GDC-0199) in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL).

John F. Seymour, Matthew S. Davids, John M. Pagel et al. · Journal of Clinical Oncology · 2013 · 33 citations

Medicine, Oncology, Pharmacology +13